Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-18

Clinical Trial Update: Weaning of Immunosuppression in Nephritis of Lupus [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the weaning of immunosuppression in lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Nephritis of Lupus | Phase 3 | Status: COMPLETED